Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. University of Virginia Health Services, Charlottesville, VA, United States

Survival: 10.4 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: United States
City/State/Province: Charlottesville, VA
Hospital: University of Virginia Health Services
Journal: Link
Date: 3/2005

Patients: This Phase II study involved 39 patients diagnosed with advanced non-small cell lung cancer. Twenty-nine patients were men, and ten were women. The median age was 62. Metastatic sites included lung, adrenal gland, and liver.

Treatment: The treatment involved two chemotherapeutic agents: gemcitabine and paclitaxel.

Toxicity: Grade 3-4 toxicities included: leucopenia, neutropenia, and dyspnea.

Results: The median overall survival was 10.4 months.

Support: Eli Lilly financially supported this study. Eli Lilly manufactures and markets gemcitabine.

Correspondence: Heidi H. Gillenwater, MD

E-mail to a Friend Email Physician More Information